partnership

Oncology

Hengrui Pharma's strategic ambition in oncology has focused on translating scientific innovation into meaningful treatment options for patients.

Patients

Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients

R&D

Gothenburg is Sweden's fastest-growing and second largest city region and one of Europe's leading innovation regions.

R&D

Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.

Digital

Bringing genuinely transformative healthcare innovations from concept to commercial reality is becoming increasingly complex.

R&D

In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.